Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke
Clinical trial NCT01098981 · TERMINATED
Trial details
- NCT number
- NCT01098981
- Sponsor
- Cerevast Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2015-04-01
- Enrollment
- 675
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.